|
3EAB
Crystal structure of Spastin MIT in complex with ESCRT III
Deposited 2008-08-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
112–196(85 aa)
Fragment:UNP residues 112 to 196
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;288 K;10% PEG 2000 MME, 0.2 M Ammonia Sulfate, 0.1 M Sodium Acetate, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 288K
|
Resolution 2.50 Å
R-free 0.268
|
|
3EAB
Crystal structure of Spastin MIT in complex with ESCRT III
Deposited 2008-08-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
112–196(85 aa)
Fragment:UNP residues 112 to 196
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;288 K;10% PEG 2000 MME, 0.2 M Ammonia Sulfate, 0.1 M Sodium Acetate, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 288K
|
Resolution 2.50 Å
R-free 0.268
|
|
3EAB
Crystal structure of Spastin MIT in complex with ESCRT III
Deposited 2008-08-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
112–196(85 aa)
Fragment:UNP residues 112 to 196
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;288 K;10% PEG 2000 MME, 0.2 M Ammonia Sulfate, 0.1 M Sodium Acetate, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 288K
|
Resolution 2.50 Å
R-free 0.268
|
|
3EAB
Crystal structure of Spastin MIT in complex with ESCRT III
Deposited 2008-08-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
112–196(85 aa)
Fragment:UNP residues 112 to 196
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;288 K;10% PEG 2000 MME, 0.2 M Ammonia Sulfate, 0.1 M Sodium Acetate, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 288K
|
Resolution 2.50 Å
R-free 0.268
|
|
3EAB
Crystal structure of Spastin MIT in complex with ESCRT III
Deposited 2008-08-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain E
112–196(85 aa)
Fragment:UNP residues 112 to 196
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;288 K;10% PEG 2000 MME, 0.2 M Ammonia Sulfate, 0.1 M Sodium Acetate, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 288K
|
Resolution 2.50 Å
R-free 0.268
|
|
3EAB
Crystal structure of Spastin MIT in complex with ESCRT III
Deposited 2008-08-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain F
112–196(85 aa)
Fragment:UNP residues 112 to 196
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;288 K;10% PEG 2000 MME, 0.2 M Ammonia Sulfate, 0.1 M Sodium Acetate, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 288K
|
Resolution 2.50 Å
R-free 0.268
|
|
3VFD
Human spastin AAA domain
Deposited 2012-01-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
228–616(389 aa)
Fragment:AAA domain
|
Mutation:E442Q
|
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;296 K;1.6M (NH3)2SO4, 0.1M MES monohydrate (pH 6.5),10% 1,4-dioxane and 4% benzamidine HCl, 1mM ATP, VAPOR DIFFUSION, HANGING DROP, temperature 296K
|
Resolution 3.30 Å
R-free 0.275
|
|
5Z6Q
Crystal structure of AAA of Spastin
Deposited 2018-01-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
229–616(388 aa)
Fragment:UNP residues 229-616
|
Not recorded
|
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;3M (NH4)2SO4, 100mM NH4Cl
|
Resolution 3.00 Å
R-free 0.276
|
|
5Z6R
SPASTIN AAA WITH ATP
Deposited 2018-01-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
229–616(388 aa)
Fragment:UNP RESIDUES 229-616
|
Mutation:E442Q
|
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.2;293 K;25MM TRIS-HCL, 1MM DTT, 1MM MGCL2, 1MM ATP, 2% PEG 3350, 20MM KSCN
|
Resolution 3.00 Å
R-free 0.279
|
|
6PEN
Structure of Spastin Hexamer (whole model) in complex with substrate peptide
Deposited 2019-06-20
|
Different construct
Different mutation/modification
Different oligomeric state
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain A
87–584(498 aa)
Chain B
87–584(498 aa)
Chain C
87–584(498 aa)
Chain D
87–584(498 aa)
Chain E
87–584(498 aa)
Chain F
87–584(498 aa)
|
Not recorded
|
ADP ADENOSINE-5'-DIPHOSPHATE × 5
BEF BERYLLIUM TRIFLUORIDE ION × 4
MG MAGNESIUM ION × 4
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.20 Å
|
|
7S7J
Structure of Human SPASTIN-IST1 complex.
Deposited 2021-09-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
112–195(84 aa)
|
Not recorded
|
PG4 TETRAETHYLENE GLYCOL × 1
CA CALCIUM ION × 1
PGE TRIETHYLENE GLYCOL × 1
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;278 K;40% v/v PEG 300, 100 mM Sodium cacodylate / Hydrochloric acid pH=6.5, 200 mM Calcium Acetate
|
Resolution 1.15 Å
R-free 0.157
|